Portfolio Companies 2026 for Venrock Healthcare Capital Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research.
Venrock Healthcare Capital Partners accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $4.2B. The median disclosed raise is $175M, and the largest is Mirador Therapeutics at $650M, ahead of Spyre Therapeutics ($644M) and RayzeBio ($418M).
The names that recur most often on these portfolio cap tables are Venrock Healthcare Capital Partners (18 companies), Fairmount (7 companies), OrbiMed (5 companies), TCGX (4 companies), Cormorant Asset Management (4 companies), Vivo Capital (4 companies). By latest disclosed round, the market skews Series A (5), Series B (4), Series D (3), Series C (3).
Companies tracked: 18
Disclosed funding total: $4.2B across 18 companies
Median disclosed raise: $175M
Largest raise: Mirador Therapeutics — $650M
Stage mix: Series A 5 · Series B 4 · Series D 3 · Series C 3
Most recent dated round: 2026-06-01
Best funded Venrock Healthcare Capital Partners companies
